Clinical Trials
7 trialsNCT06140524 2026-06-04
LINKER-MGUS1
Regeneron Pharmaceuticals
Phase 2 Recruiting
NCT01222286 2026-05-14
KIRMONO
Innate Pharma
Phase 2 Completed
NCT06472778 2026-05-08
A Real-world Study in Participants With Smoldering Multiple Myeloma
Janssen-Cilag Ltd.
Completed
NCT02316106 2026-04-23
A Study to Evaluate 3 Dose Schedules of Daratumumab in Participants With Smoldering Multiple Myeloma
Janssen Research & Development, LLC
Phase 2 Completed
NCT03301220 2026-04-13
A Study of Subcutaneous Daratumumab Versus Active Monitoring in Participants With High-Risk Smoldering Multiple Myeloma
Janssen Research & Development, LLC
Phase 3 Active not recruiting
NCT05955508 2026-04-13
A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult Participants With Smoldering Multiple Myeloma at High Risk of Developing Multiple Myeloma
Regeneron Pharmaceuticals
Phase 2 Active not recruiting
NCT07393282 2026-03-16
LINKER-SMM2
Regeneron Pharmaceuticals
Phase 3 Not yet recruiting